Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme

Cancer

Volumn 113, Issue 4, 2008, Pages 841-846

  Mangiola, Annunziato ^a   De Bonis, Pasquale ^a   Maira, Giulio ^a   Balducci, Mario ^a   Sica, Gigliola ^a   Lama, Gina ^a   Lauriola, Libero ^a   Anile, Carmelo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Adjuvant therapy; Glioblastoma multiforme; Gross total resection; Invasion; Prognosis

Indexed keywords

TEMOZOLOMIDE;

AGE; AGED; ARTICLE; CANCER INFILTRATION; CANCER PATIENT; CANCER SURVIVAL; CELL INFILTRATION; CLINICAL ARTICLE; DRUG DOSE INCREASE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; LYMPHOCYTOPENIA; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; THROMBOCYTOPENIA; TUMOR CELL; UNIVARIATE ANALYSIS; WHITE MATTER;

AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 50249096363     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23624     Document Type: Article

References (21)

1. Kallio M, Sankila R, Jaaskelainen J, et al. A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984. Cancer. 1991; 68:1394-1400.
2. Davis FG, Freels S, Grutsch J, et al. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg. 1998;88:1-10.
3. Curran WJ Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in 3 Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993;85:704-710.
4. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190-198.
5. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-996.
6. Burger PC, Dubois PJ, Schold SC Jr, et al. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg. 1983;58:159-169.
7. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol. 2003;21:1624-1636.
8. Hoelzinger DB, Mariani L, Weis J, et al. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia. 2005;7:7-16.
9. Di Costanzo A, Trojsi F, Giannatempo GM, et al. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results. J Exp Clin Cancer Res. 2006;25:383-390.
10. Mangiola A, Lama G, Giannitelli C, et al. Stem cell marker Nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Clin Cancer Res. 2007;13:6970-6977.
11. Shinoda J, Sakai N, Murase S, et al. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol. 2001;52:161-171.
12. Sawaya R, Hammoud M, Schoppa D, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery. 1998;42:1044-1056.
13. Wigner MJ, MacDonald DR, Cairncross JG. Supratentorial anaplastic gliomas in adults: the prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg. 1989;71:487-493.
14. Simpson JR, Horton J, Scott C, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of 3 consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys. 1993;26:239-244.
15. Sneed PK, Prados MD, McDermott MW, et al. Large effect of age on survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery. 1995;36:898-903.
16. Salminen E, Nuutinen JM, Huhtala S. Multivariate analysis of prognostic factors in 106 patients with malignant glioma. Eur J Cancer. 1996;32:1918-1923.
17. Kowalczuk A, MacDonald RL, Amidei C, et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery. 1997;41:1028-1036.
18. Silbergeld DL, Chicoine MR. Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg. 1997;86:525-531.
19. Schiffer D, Cavalla P, Dutto A, Borsotti L. Cell proliferation and invasion in malignant glioma. Anticancer Res. 1997;17: 61-69.
20. Dalrymple SJ, Parisi JE, Roche PC, et al. Changes in proliferating cell nuclear antigen expression in glioblastoma multiforme cells along a stereotactic biopsy trajectory. Neurosurgery. 1994;35:1036-1044.
21. Berens ME, Giese A. "... Those left behind." Biology and oncology of invasive glioma cells. Neoplasia. 1999;1:208-219.